Kenneth Lin

Kenneth Lin

Director/Board Member at ANEBULO PHARMACEUTICALS, INC.

Net worth: - $ as of 31/03/2024

51 year
Finance
Health Technology
Consumer Services

Profile

Kenneth S.
Lin
was the founder of Ab Initio Biotherapeutics, Inc. founded in 2015, where he held the position of President & Chief Executive Officer until 2019.
Currently, he is an Independent Director at Anebulo Pharmaceuticals, Inc. since 2021 and an Advisor at Tarrant Capital IP LLC since 2008.
Dr. Lin's former positions include Director at Vibrynt, Inc. and Conventus Orthopaedics, Inc., VP-Corporate Development & Investor Relations at Ulthera, Inc. from 2012 to 2014, Research Associate at Goldman Sachs & Co. LLC from 2000 to 2002, Associate at J.P.
Morgan Partners LLC and Panorama Capital LLC, and Vice President at TPG, Inc. from 2008 to 2012.
Dr. Lin's education includes an undergraduate degree from Stanford University in 1994 and a doctorate degree from Case Western Reserve University in 1999.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/09/2023 0 ( -.--% ) - $ 31/03/2024

Kenneth Lin active positions

CompaniesPositionStart
ANEBULO PHARMACEUTICALS, INC. Director/Board Member 01/02/2021
Corporate Officer/Principal 13/06/2012
All active positions of Kenneth Lin

Former positions of Kenneth Lin

CompaniesPositionEnd
Chief Executive Officer 01/07/2019
Investor Relations Contact 01/07/2014
TPG INC. Corporate Officer/Principal 01/06/2012
Corporate Officer/Principal 31/12/2007
Analyst-Equity 31/12/2002
See the detail of Kenneth Lin's experience

Training of Kenneth Lin

Stanford University Undergraduate Degree
Case Western Reserve University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kenneth Lin's experience

Connections

100 +

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
TPG INC.

Finance

Private companies9

Health Technology

Health Technology

Health Services

Finance

Finance

Finance

Finance

Health Technology

Anebulo Pharmaceuticals, Inc.

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW